Pharma Journalist -

Takeda Pharmaceutical Company Limited announced the completion of its acquisition of Shire plc, becoming a global, values-based, R&D-driven biopharmaceutical leader headquartered in…
Read More...

AbSci announced a collaboration with Sanofi.  Under the terms of the agreement, AbSci will apply its breakthrough E.coli manufacturing platform, SoluProTM, and its novel optimization…
Read More...

Pharmaceutics International announced its partner, Academic Pharmaceuticals, Inc., received FDA approval of Bretylium Tosylate Injection USP, 500 mg/10 mL (50 mg/mL) Single-Dose Vials…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has granted crizanlizumab (SEG101) Breakthrough Therapy designation for the prevention of vaso-occlusive crises (VOCs)…
Read More...

Almac Sciences, a member of the Almac Group, has expanded its technology capabilities within its Active Pharmaceutical Ingredients (API) services & chemical development portfolio…
Read More...

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on novel, disease-modifying therapies for neurodegenerative diseases announced its plans to initiate a…
Read More...

Aphena Pharma Solutions Inc. has announced the expansion of its blister packaging capacity with the purchase of a PharmaWorks TF2 blister packaging line with in-line cartoning…
Read More...

Ascentage Pharma announced that Unity Biotechnology has selected one of Ascentage's compounds as its lead development candidate in its ophthalmology pipeline to advance into further…
Read More...

Generex Biotechnology Corporation announced that the company has completed the acquisition of 51% of Olaregen Therapeutix Inc., a New York based regenerative medicine company that is…
Read More...

CANbridge Pharmaceuticals and WuXi Biologics jointly announced an expansion of their rare disease partnership to enable CANbridge to discover, develop and commercialize four additional…
Read More...